AGM - Our time to stand up, page-26

First 26 Last

Share
Profile

Follow
J8

14,544 Posts.

822

08/11/18

12:29

Post #: 36432001
Share

Originally posted by Blane66 ↑

Originally posted by scout41
NANT TNBC and head and neck data 

Results
To date, 3 patients with 3rd-line or greater TNBC and 2 patients with 4th-line or greater HNSCC have been treated with the NANT Cancer Vaccine. All treatment was completed in the outpatient setting, with no immune-related adverse events. Two of the three patients with TNBC experienced partial response (78% and 62% decrease by irRC). Both patients with HNSCC experienced objective tumor response (100% and 47% decrease by irRC). Four hematologic DLT’s were observed and managed with a planned dose reduction of cisplatin. All responding patients are still
undergoing therapy.

Conclusions
This preliminary data suggests that the NANT Cancer Vaccine of low-dose chemoradiation combined with innate and adaptive immunotherapy can be administered safely in an outpatient setting without any observed increased irAE’s. Preliminary efficacy result of four out of five patients (80%) with confirmed overall responses, with one of these four patients demonstrating a complete response with 5th-line metastatic disease is encouraging.
Awesome find scout. My only fear is given the small “n” number, the response may be mediocre. The results are positive, but extremely narrow. The Nasdaq hasn’t even budged with this so far, so let’s see what happens at the AGM.

Expand

This is not from the current trial, so why the big deal?

Sorry, I don't get it.

BLT Price at posting: 15.5¢ Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

FG1

Flynn Gold flags mid-grade drill hits and always eye-catching rock chips

Week 29 Wrap: Trump in spotlight again; China's Third Plenum a yawnfest; RBA's August move a mystery

LKE

Lake Resources implies news article on job cuts made up; non-core sales "not material" and no rule 15.7 breach

IMR

Imricor raises $35M to pursue growth and expansion into Australia and NZ

MCT

Metalicity looking for offers on Admiral Bay zinc project

Wealth Within considers potential takeover targets in Australia's booming infrastructure industry

GNX

NSW approves J-POWER's $380M buyout of Genex Power, giving it ownership of QLD net zero project

Warren Tredrea’s weekly sports business wrap: the latest on business in sport

AI stocks: What to expect in 2024-25

Talking Australia's very competitive property landscape: Realty Talks

There are more pages in this discussion • 18 more messages in this thread...

First 26 Last

Add BLT (ASX) to my watchlist

AGM - Our time to stand up, page-26

Top Stories

Flynn Gold flags mid-grade drill hits and always eye-catching rock chips

Week 29 Wrap: Trump in spotlight again; China's Third Plenum a yawnfest; RBA's August move a mystery

Lake Resources implies news article on job cuts made up; non-core sales "not material" and no rule 15.7 breach

Imricor raises $35M to pursue growth and expansion into Australia and NZ

Metalicity looking for offers on Admiral Bay zinc project

Wealth Within considers potential takeover targets in Australia's booming infrastructure industry

NSW approves J-POWER's $380M buyout of Genex Power, giving it ownership of QLD net zero project

Warren Tredrea’s weekly sports business wrap: the latest on business in sport

AI stocks: What to expect in 2024-25

Talking Australia's very competitive property landscape: Realty Talks

Featured News